More SEC Filings
View Older Stories View Newer Stories-
Form SCHEDULE 13G/A BrightSpire Capital, Filed by: Nut Tree Capital Management, LP
-
Form SCHEDULE 13G Core AI Holdings, Inc. Filed by: Alyeska Investment Group, L.P.
-
Form N-PX Abingworth LLP For: Jun 30
-
Form N-23C-2 Eaton Vance Senior Incom For: Aug 14
-
Form SCHEDULE 13G/A Eightco Holdings Inc. Filed by: CoinFund Management LLC
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 13F-NT Coatue Structured Fund For: Jun 30
-
Form 10-Q Catheter Precision, Inc. For: Jun 30
-
Form 13F-NT BofA Securities Europe For: Jun 30
-
Form 4 Inflection Point Acquisi For: Aug 12 Filed by: Inflection Point Asset Management LLC
-
Form 13F-NT D. E. Shaw Investment For: Jun 30
-
Form SCHEDULE 13G/A Kura Oncology, Inc. Filed by: MONTANOVA CAPITAL, LLC
-
Form 13F-HR Collaborative Capital For: Jun 30
-
Form 3 CLARIVATE PLC For: Aug 08 Filed by: Lisowski Matthew J.
-
Form SCHEDULE 13G Braveheart Bio, Inc. Filed by: Frazier Life Sciences Public Fund, L.P.
-
Form 13F-HR Notable Capital Manageme For: Jun 30
-
Form SCHEDULE 13G/A Cantor Equity Partners Filed by: Alyeska Investment Group, L.P.
-
Form SCHEDULE 13G/A Viridian Therapeutics, Filed by: Paradigm Biocapital Advisors LP
-
Form 424B2 CABOT CORP
-
Form SCHEDULE 13G/A Braze, Inc. Filed by: Battery Ventures XI-A, L.P.
-
Form N-PX Sanchez Gaunt Capital For: Jun 30
-
Form 424B2 MORGAN STANLEY
-
Form 424B2 JPMORGAN CHASE & CO
-
Form SCHEDULE 13G Suncrete, Inc. Filed by: Alyeska Investment Group, L.P.
-
Form 144 EverCommerce Inc. Filed by: Remer Eric Richard
-
Form 13F-HR Point72 Private Investme For: Jun 30
-
Form 13F-NT Pershing Square Partner For: Jun 30
-
Form 8-K Solana Co For: Aug 14
-
Form 10-Q Obsidian Therapeutics, For: Jun 30
-
Form 13F-NT Fortress LHB Advisors For: Jun 30
-
Form 13F-HR STADIUM CAPITAL MANAGEME For: Jun 30
-
Form NT 10-Q BioRestorative Therapies For: Jun 30
-
Form SCHEDULE 13G/A ABEONA THERAPEUTICS INC. Filed by: MONTANOVA CAPITAL, LLC
-
Form SCHEDULE 13G/A Core Scientific, Inc./tx Filed by: Pentwater Capital Management LP
-
Form SCHEDULE 13G/A Vor Biopharma Inc. Filed by: Frazier Life Sciences Public Fund, L.P.
-
Form SCHEDULE 13G/A Bakkt, Inc. Filed by: Alyeska Investment Group, L.P.
-
Form SCHEDULE 13G/A Health Catalyst, Inc. Filed by: Stoney Lonesome HF LP
-
Form SCHEDULE 13G/A Avidbank Holdings, Inc. Filed by: Fourthstone LLC
-
Form 10-Q FEMASYS INC For: Jun 30
-
Form 8-K Seritage Growth Properti For: Aug 14
-
Form 13F-HR Visualize Group LP For: Jun 30
-
Form SCHEDULE 13G/A AMC ENTERTAINMENT HOLDIN Filed by: Pentwater Capital Management LP
-
Form SCHEDULE 13G Conexeu Sciences Inc. Filed by: OnePointTwo Capital Ventures LLC
-
Form SCHEDULE 13G/A Nine Energy Service, Filed by: GENDELL JEFFREY L
-
Form SCHEDULE 13G/A Arcellx, Inc. Filed by: Paradigm Biocapital Advisors LP
-
Form 13F-NT D. E. SHAW & CO, L.P. For: Jun 30
-
Form NT 10-Q Bravo Multinational Inc. For: Jun 30
-
Form SCHEDULE 13G/A BRC Inc. Filed by: Alyeska Investment Group, L.P.
-
Form SCHEDULE 13G Cerebras Systems Inc. Filed by: Atreides Management, LP
-
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: MONTANOVA CAPITAL, LLC
